Who Exports Lorazepam from India — 24 Suppliers Behind a $2.5M Market
India's lorazepam export market is supplied by 24 active exporters who collectively shipped $2.5M across 125 shipments. APL HEALTHCARE LIMITED leads with a 37.7% market share, followed by CENTAUR PHARMACEUTICALS PRIVATE LIMITED and VENOR PHARMA LIMITED. The top 5 suppliers together control 79.6% of total export value, reflecting a concentrated market structure.
Top Lorazepam Exporters from India — Ranked by Export Value
APL HEALTHCARE LIMITED is the leading lorazepam exporter from India, holding a 37.7% share of the $2.5M market across 125 shipments from 24 exporters. The top 5 suppliers — APL HEALTHCARE LIMITED, CENTAUR PHARMACEUTICALS PRIVATE LIMITED, VENOR PHARMA LIMITED, ESJAY PHARMA PRIVATE LIMITED, J B CHEMICALS AND PHARMACEUTICALS LIMITED — collectively control 79.6% of total export value, indicating a highly concentrated market. Individual shares are: APL HEALTHCARE LIMITED (37.7%), CENTAUR PHARMACEUTICALS PRIVATE LIMITED (18.8%), VENOR PHARMA LIMITED (9.0%), ESJAY PHARMA PRIVATE LIMITED (8.0%), J B CHEMICALS AND PHARMACEUTICALS LIMITED (6.2%).
Top Lorazepam Exporters from India
Ranked by export value · 24 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | APL HEALTHCARE LIMITED LORAZEPAM TABLETS USP 1MGLORAZEPAM TABLETS USP 0.5MGLORAZEPAM TABLETS USP 2MG | $947.1K | 1 | 37.7% |
| 2 | CENTAUR PHARMACEUTICALS PRIVATE LIMITED LORAZEPAM 0.50MG 4X7TABS UK EXP EXPORTLORAZEPAM ORION 1MG / TABLETS- PACK SIZELORAZEPAM 0.50MG TABLETS - PACK SIZE: 4 X 7'S UK EXP | $471.7K | 4 | 18.8% |
| 3 | VENOR PHARMA LIMITED PHARMACEUTICALS:BRAND. LORZIVER LORAZEPAM TAB. USP 1MG.BRAND VERALPAM TAB LORAZEPAM USP 1MG BN. | $227.2K | 3 | 9.0% |
| 4 | ESJAY PHARMA PRIVATE LIMITED LORAZEPAM TABLETS USP 1MGLORAZEPAM TABLETS USP 0.5MGLORAZEPAM TABLETS USP 2MG | $200.0K | 1 | 8.0% |
| 5 | J B CHEMICALS AND PHARMACEUTICALS LIMITED LORAZEPAM TABLETS USP 1MGLORAZEPAM TABLETS USP 0.5MGLORAZEPAM TABLETS USP 2MG | $156.3K | 2 | 6.2% |
| 6 | J B CHEMICALS PHARMACEUTICALS LIMITED LORAZEPAM TABLETS USP 1MGLORAZEPAM TABLETS USP 0.5MGLORAZEPAM TABLETS USP 2MG | $133.9K | 1 | 5.3% |
| 7 | CENTAUR PHARMACEUTICALS PVT LTD LORAZEPAM 0.50MG 4X7TABS UK EXP EXPORTLORAZEPAM ORION 1MG / TABLETS- PACK SIZELORAZEPAM 0.50MG TABLETS - PACK SIZE: 4 X 7'S UK EXP | $81.2K | 2 | 3.2% |
| 8 | HIRAL LABS LIMITED LORAZEPAM USP TABLETS GUMAZEPAM TABLET PINDIAN HARMLESS MEDICINE:LORAZEPAM 2MG TLORAZEPAM -2MG TABLETS : | $31.5K | 1 | 1.3% |
| 9 | CENTURION HEALTHCARE PRIVATE LIMITED BRAND VERALPAM TAB LORAZEPAM USP 1MG BN. | $28.9K | 2 | 1.2% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Lorazepam exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| APL HEALTHCARE LIMITED | Approved | Yes | Yes | 12 | FDA inspections in 2023 resulted in No Action Indicated (NAI) and Voluntary Acti |
| CENTAUR PHARMACEUTICALS PRIVATE LIMITED | Warning Letter, June 2023 | Yes | Yes | 12 | Received FDA warning letters in June and July 2023 for CGMP violations at Ambern |
TransData Nexus reviewed the regulatory standing of 2 leading Lorazepam exporters from India. 1 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 2 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Lorazepam sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. The city hosts numerous pharmaceutical companies specializing in active pharmaceutical ingredients (APIs) and intermediates. Notable firms include A.R. Life Sciences, which manufactures a wide range of APIs for various treatments, and Hy-Gro Chemicals, known for its cost-effective and quality-driven API production. The establishment of Hyderabad Pharma City aims to further enhance the region's pharmaceutical ecosystem by integrating manufacturing, research and development, and sustainable living environments.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a prominent hub for pharmaceutical formulations. Vadodara, in particular, is home to Alembic Pharmaceuticals, a multinational company specializing in formulations for therapeutic areas such as cardiology, dermatology, and infectious diseases. Additionally, companies like Schwitz Biotech in Ahmedabad offer a wide range of pharmaceutical formulations, including tablets, capsules, and injectables, adhering to international quality standards. The region's focus on formulations is supported by a robust infrastructure and a skilled workforce, making it a key player in India's pharmaceutical industry.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates the export of pharmaceutical products to various international markets. Companies like Formel Labs, with facilities in both Mumbai and Hyderabad, are committed to producing safe and effective medicines, ensuring that products meet international standards. The region's strategic location and well-developed logistics infrastructure make it an ideal hub for pharmaceutical exports.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, primarily due to favorable tax incentives offered by the government. This area attracts numerous pharmaceutical companies seeking cost-effective production solutions. The presence of WHO-GMP-certified manufacturing units and a focus on quality and regulatory compliance make Baddi-Nalagarh a preferred destination for pharmaceutical manufacturing.
5Sourcing Recommendations
- Diversify Supplier Base: To mitigate risks associated with supplier concentration, consider engaging with multiple suppliers across different regions, such as Hyderabad for APIs and Ahmedabad-Vadodara for formulations.
- Evaluate Supplier Capabilities: Assess potential suppliers' manufacturing capabilities, quality standards, and regulatory compliance to ensure they meet international requirements.
- Leverage Export Hubs: Utilize regions like Mumbai-Thane-Raigad for efficient export logistics, taking advantage of their well-established infrastructure.
- Consider Cost Advantages: Explore manufacturing options in tax incentive zones like Baddi-Nalagarh to benefit from cost savings while maintaining product quality.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Lorazepam exporters from India
J. B. Chemicals & Pharmaceuticals Limited — Torrent Pharma acquires J. B. Chemicals with CCI approval
The Competition Commission of India (CCI) approved Torrent Pharmaceuticals Limited's acquisition of J. B. Chemicals & Pharmaceuticals Limited, subject to voluntary modifications to ensure fair competition. - IMPACT: This consolidation may enhance production capabilities and potentially increase Lorazepam exports.
Impact: This consolidation may enhance production capabilities and potentially increase Lorazepam exports.
Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million
Sun Pharma acquired Checkpoint Therapeutics, a company specializing in immunotherapy and targeted oncology treatments, for $355 million. - IMPACT: While primarily focused on oncology, this acquisition may lead to expanded research and development resources, indirectly affecting Lorazepam production.
Impact: While primarily focused on oncology, this acquisition may lead to expanded research and development resources, indirectly affecting Lorazepam production.
Amneal Pharmaceuticals — Amneal acquires Punishka Healthcare to expand injectable manufacturing
Amneal Pharmaceuticals acquired Punishka Healthcare, enhancing its capacity to manufacture injectable medications at a 293,000 sq. foot facility near Ahmedabad, India. - IMPACT: This expansion may bolster Amneal's production capabilities, potentially increasing Lorazepam exports.
Impact: This expansion may bolster Amneal's production capabilities, potentially increasing Lorazepam exports.
Common Questions — Lorazepam Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which lorazepam supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, APL HEALTHCARE LIMITED leads with 19 recorded shipments worth $947.1K. CENTAUR PHARMACEUTICALS PRIVATE LIMITED (30 shipments) and VENOR PHARMA LIMITED (3 shipments) are also established high-volume exporters.
Q How many lorazepam manufacturers are there in India?
India has 24 active lorazepam exporters with a combined export market of $2.5M across 125 shipments to 21 countries. The top 5 suppliers hold 79.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for lorazepam from India?
Average FOB unit price: $2.38 per unit, ranging from $0.01 to $48.58. Average shipment value: $20.1K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 24 verified Indian exporters of Lorazepam ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 125 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 21 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
125 Verified Shipments
24 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists